KAKEN PHARMACEUTIAL CO., LTD.
4521 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 文京区本駒込二丁目２８番８号
- Website:
- https://www.kaken.co.jp/english/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
KAKEN PHARMACEUTICAL CO., LTD. is a prominent Japanese pharmaceutical company focused on the research, development, manufacturing, and marketing of innovative healthcare solutions. With a strong commitment to sustainability, Kaken integrates environmental, social, and governance (ESG) initiatives into its operations, aiming to create value for society while addressing priority health issues. The company is dedicated to advancing medical science and improving patient outcomes through its diverse product portfolio, which includes prescription drugs and over-the-counter medications. Kaken emphasizes transparency and stakeholder engagement, regularly updating its community on corporate governance and strategic business plans to foster trust and collaboration.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-09 08:16 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.9 KB | |
| 2025-07-01 02:34 |
Inside Information Statement
臨時報告書
|
Japanese | 28.2 KB | |
| 2025-06-26 03:41 |
Internal Control over Financial Reporting
内部統制報告書－第105期(2024/04/01－2025/03/31)
|
Japanese | 24.6 KB | |
| 2025-06-26 03:39 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-06-26 03:38 |
Annual Report
有価証券報告書－第105期(2024/04/01－2025/03/31)
|
Japanese | 1.8 MB | |
| 2025-06-11 06:41 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.7 KB | |
| 2025-05-30 08:42 |
Inside Information Statement
臨時報告書
|
Japanese | 84.4 KB | |
| 2025-05-14 05:01 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.3 KB | |
| 2025-04-10 04:16 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.5 KB | |
| 2025-03-12 02:56 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.1 KB | |
| 2024-12-26 07:35 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 82.4 KB | |
| 2024-11-13 05:25 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-11-13 05:24 |
Interim Report
半期報告書－第105期(2024/04/01－2025/03/31)
|
Japanese | 243.3 KB | |
| 2024-08-23 08:24 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 129.0 KB | |
| 2024-07-01 03:36 |
Inside Information Statement
臨時報告書
|
Japanese | 27.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
iDNA Genomics Public Ltd | Cyprus | IDNA | |
|
Idorsia Ltd | Switzerland | IDIA | |
|
ILIKA PLC | United Kingdom | IGE | |
|
Immuno-Biological Laboratories Co., Ltd. | Japan | 4570 | |
|
Indivior PLC | United Kingdom | INDV | |
|
Infant Bacterial Therapeutics | Sweden | IBT | |
|
Initiator Pharma A/S | Denmark | INIT | |
|
Intercure Ltd. | Israel | INCR | |
|
Intervacc AB | Sweden | IVACC | |
|
Ipsen | France | IPN |